key: cord-0726452-d8uu54fg authors: Georgiadis, Georgios P.; Georgiadis, Michael C. title: Optimal Planning of the COVID-19 Vaccine Supply Chain date: 2021-07-27 journal: Vaccine DOI: 10.1016/j.vaccine.2021.07.068 sha: 934c0c38f266b79f0f390a53f8d058dbf0fb9094 doc_id: 726452 cord_uid: d8uu54fg This work presents a novel framework to simultaneously address the optimal planning of COVID-19 vaccine supply chains and the optimal planning of daily vaccinations in the available vaccination centres. A new mixed integer linear programming (MILP) model is developed to generate optimal decisions regarding the transferred quantities between locations, the inventory profiles of central hubs and vaccination centres and the daily vaccination plans in the vaccination centres of the supply chain network. Specific COVID-19 characteristics, such as special cold storage technologies, limited shelf-life of mRNA vaccines in refrigerated conditions and demanding vaccination targets under extreme time pressure, are aptly modelled. The goal of the model is the minimization of total costs, including storage and transportation costs, costs related to fleet and staff requirements, as well as, indirect costs imposed by wasted doses. A two-step decomposition strategy based on a divide-and-conquer and an aggregation approach is proposed for the solution of large-scale problems. The applicability and efficiency of the proposed optimization-based framework is illustrated on a study case that simulates the Greek nationwide vaccination program. Finally, a rolling horizon technique is employed to reactively deal with possible disturbances in the vaccination plans. The proposed mathematical framework facilitates the decision-making process in COVID-19 vaccine supply chains into minimizing the underlying costs and the number of doses lost. As a result, the efficiency of the distribution network is improved, thus assisting the mass vaccination campaigns against COVID-19. The unprecedented effects of SARS-COV-2 virus have risen an immense global interest regarding the development and distribution of safe and effective vaccines. Worldwide, more than 160 million people have been already infected, while close to 3.5 million passed away. In addition, the necessitated protective measures, and lengthy lockdowns have a severe financial impact on the society. The urge to rapidly decrease the toll of COVID-19 on health and global economy led to the rapid authorization of various vaccine candidates within a record time. While the focus in the vaccine world has been on developing the required vaccines and measuring their effectiveness, the struggle to understand and properly address the issues of the Vaccine Supply Chain (VSC), greatly reduces the impact of any vaccination program [1] . Mass vaccination of the world's population will achieve herd immunity, the first step for the progressive transition to the pre-COVID-19 normalcy. As a result, the biggest vaccination program in human history is currently in action pushing the COVID-19 VSC to its limits. Furthermore, special characteristics, like limited shelf life and storage requirements in freezing conditions, makes its management a critical logistical challenge. Efficient and effective planning and operation of the supply chain is critical for the success of the vaccination program, otherwise, numerous valuable doses will be wasted, and the program's progress will slow down, imposing important financial losses. Few studies focus on VSCs, despite the substantial published research on supply chain optimization. Most related studies are concerned with problems related to the pharmaceutical sector [2] - [8] . More recent contributions address key problems of the pharmaceutical supply chain, like vehicle routing decisions [9] , [10] , uncertainty [11] , product perishability [12] and integrated capacity planning and scheduling [13] , while few recent contributions focused on supply chains of CAR T-cell therapies [14] - [16] . Lately, the scientific community has shown an increasing interest in VSCs [17] - [19] , especially on the design/redesign problem of VSC networks in developing countries [20] - [22] . Two extensive literature reviews on the topic of VSCs were recently published [23] , [24] . The optimal planning of the supply chain network has a strong positive effect on its efficiency. Therefore, a plethora of mathematical programming models have been proposed to address this problem [25] - [27] . Despite, the rich literature, only a handful of contributions consider the optimal planning of VSCs. Chen et al. developed the first planning model for a World Health Organization's Expanded Program on Immunization (WHO-EPI) distribution chain in developing countries [28] . Another study proposed a multi-objective, multi-period Mixed-Integer Linear Programming (MILP) model to address the simultaneous optimal design and planning of sustainable VSCs [29] . Trade-offs between the sustainability dimensions considered (economic, environmental, and social) are highlighted. Recently, Yang investigated the optimal design and operation of WHO-EPI vaccine distribution chains [30] . The author developed an MILP model and a disaggregation-merging technique to generate optimal solutions for real-world cases. Recently, Kontoravdi et al. presented a thoughtful discussion on the production phase of the vaccine [31] . The distribution phase of the COVID-19 supply chain has not been studied so far. A few contributions focus on the effect of the COVID-19 pandemic on other distribution supply chains [32] . The COVID-19 distribution chain displays special characteristics that differentiate them from other VSCs. A prominent concern regarding the distribution of COVID-19 vaccines is the strict temperature requirements during transportation and storage. Inefficient planning can lead to losses of many valuable doses and thus to increased operational costs. These negative implications are further amplified due to the enormous scale of the COVID-19 vaccination programs. In this work, a new MILP model is presented for the optimal short-term planning of the COVID-19 supply chain network. Tactical and operational decisions regarding the inventory levels in the central hubs and vaccination centres, the vaccine flows between the various locations of the distribution network, the fleet requirements, the scheduling of citizens' vaccinations, as well as, staffing of the vaccination centres are simultaneously considered. The goal of the optimization is the minimization of cost. While previous works have addressed the medium-term VSC planning problem, the developed model is the first to consider key issues of the COVID-19 supply chain, like storage and supply limitations, multiple cold storage technologies, demanding vaccination targets, transportation lead-times and vaccine perishability. Moreover, the literature models focus on economic or social objectives and do not take into account the minimization of wasted doses, a critical target for the effectiveness of the COVID-19 vaccination program. In addition of considering the minimization of dose wastage, the developed model is the first to simultaneously take optimal short-term decisions for the VSC and planning decisions for the vaccination program in each vaccination centre. Integrating these decisions enhances the efficiency of the overall vaccination program. An MILPbased solution strategy is introduced for the efficient solution of large-scale realistic case studies and is successfully applied to a case simulating the Greek COVID-19 VSC. Furthermore, a rolling-horizon technique is incorporated to replan the supply chain, in case of demand fluctuations originating from citizens that reschedule their vaccination appointment at the last minute or cancel a scheduled appointment. To the best of our knowledge this is one of the first contributions that examines the optimal planning of COVID-19 VSCs by integrating all key planning decisions for the efficient and cost effective realization of the citizens' vaccinations program. The problem addressed in this work considers the optimal short-term planning of the COVID-19 VSC, as well as the optimal planning of appointments in the vaccination centres, in order to minimize the total costs. Figure 1 illustrates a generic representation of the underlying network. The supply chain consists of three echelons: the manufacturing plants with a known maximum production capacity, the hubs, where the vaccine vials are stored and the vaccination centres, where the citizens are vaccinated. The product (vaccines) flow is unidirectional, from the manufacturers to the hubs and finally to the vaccination centres. Reverse flows from the vaccination centres to the hubs are not allowed, while intralayer flows between the hubs or the vaccination centres are not considered. Finally, the vaccines are used in the vaccination program of the population. Planning of the appointments is considered simultaneously with the planning the distribution of the COVID-19 vaccines. The capacity of the vaccination centres varies according to the employed healthcare personnel. To properly consider the low shelf-life of sensitive vaccines (5 days), a 14-day horizon is considered. The problem is described in terms of an MILP model that relies on a daily discretization of the time horizon. Within the given horizon a specific number of completed appointments must be satisfied. The model distributes them throughout the available periods. As a result, optimal decisions regarding the daily appointments at each centre are generated, which impose the needs in healthcare personnel. vials that are not fully exploited or due to expiration and c) the needs in healthcare personnel and fleet size to realize the vaccination program, so that the total cost of the supply chain is minimized. A cost term considers the valuable doses being wasted, while a backlog term is not included, since failing to realize a scheduled appointment is not allowed. Finally, the proposed framework examines a mature COVID-19 VSC, where vaccine availability issues have been overcome. In this chapter the MILP-based mathematical frameworks that have been developed to deal with the optimization problem of planning the COVID-19 VSC are presented. The proposed model utilizes a discrete time grid to efficiently capture the inventory balances in the various locations of the supply chain. The constraints related to the material balances, inventory capacities and vaccine flows are inspired by the model proposed by Carvalho et al. [29] . In addition to the material balance, inventory capacity and flow limitation constraints, the proposed model periods, the constraints remain the same, but instead of using the initial inventory, the inventory of the previous period is used. Similarly, constraints (6) and (7) vial flows between locations are incorporated with constraints (12) and (13) . Notice that when a connection is not realized in time period t ( ), the associated transferred quantities ( ) , , = 0 , , , are pushed to zero. At this point we should note, that while many variables are associated with an integer number of vaccines, e.g. X f,h,v,t , S h,v,t etc., they are modelled as continuous variables. This is done to allow the prompt generation of optimal decisions. Modelling these variables as integer would result to a computationally intractable model even for medium-sized problem instances. To generate integer decisions, one could manually round the non-integer solution extracted by the model. Alternatively, the generated non-integer solution can be used as an initial solution for the same model, but with these variables defined as integer. , , , , , , , An important characteristic of the studied supply chain concerns the required transportation time between the supply chain nodes. Theoretically, within the same day a vial could be transferred from the manufacturers to the hubs and then the vaccination centres to be used. However, this would require a finer discretization of time, thus resulting in large and computationally intractable models. Therefore, to ensure the feasibility of the proposed logistics operations using a daily discretization, it is assumed that a vial that is transferred from a manufacturing plant to a hub in period t, can only be further transferred to a vaccination centre after the next period (t+1). The same holds for the hubs to vaccination centres connections. So, a transportation lead time of one time period is included in the proposed model. These considerations are introduced to the model through constraints (14) and (15) . Figure 2 illustrates the role of the constraint for the vaccination centres. More specifically, the vials of vaccine v used in the vaccination plan in a vaccination centre for all periods , have to be t t   less than or equal to the initial inventory of vials plus the vials that arrived from the hubs in all periods , minus the vials lost in the same periods. To incorporate shelf-life issues in the model, a new variable is introduced, which defines the , , , , The daily vaccination appointments in vaccination centre vc and period t ( ) are calculated as , Constraints (24) and (25) The vaccine doses wasted due to open vials that are not completely used within a period are included in the model using constraints (28) . An integer variable is introduced to calculate the actual , , , An economic objective that minimizes the total cost of the VSC, consisting of i) the storage costs, ii) the distribution costs (fuel consumption and drivers' wages), iii) the compensation for any additional healthcare personnel, iv) the wasted doses and v) the rental cost of the fleet, is considered (29) . For the solution of large problems, an MILP-based strategy, based on a decomposition algorithm is employed. Let us assume a relatively small problem with one manufacturing plant, two hubs and 20 vaccination centres. The problem is decomposed employing the following rationale. First, the problem is divided into two subproblems, one for each hub, where the vaccination centres are preallocated to the closest hub. This assumption is motivated by the observation that in large problems, the vaccination centres will never be supplied by the hubs that are far away from them. So, this approach does not strongly affect the quality of the solution, however, it reduces immensely the combinatorial complexity of the problem, since many binary variables (connections of hubs to vaccination centres) are predefined. Next, the vaccination centres are grouped into clusters based on existing political boundaries. As shown in Figure 3 , four clusters are generated, two for each subproblem. Then, the two subproblems are solved using the cluster entities, instead of the vaccination centres. To generate the models, all related parameters of the vaccination centres, e.g. vaccination targets, storage capacities etc. are aggregated to extract the parameters for each cluster. Through this aggregated approach, small problems that can be quickly solved are generated. The solution of these models proposes optimal decisions considering the clusters as the last echelon of the VSC. To disaggregate these decisions an additional step is introduced. Here, all binary variables are fixed, and the previous solution is used as a start point for the solver, meaning that in case hub h is supplying vaccines to cluster cl in time period t ( ), then at this time period the hub will Conclusively, the proposed solution strategy consists of two steps. In the first step, small subproblems are generated, first through a divide-and-conquer approach that creates MILPsubproblems for each hub, and then by an aggregation technique that reduces the number of involved entities, by grouping the vaccination centres into clusters. At this point the reduced MILPsubproblems are solved to provide optimal solutions for the clusters. In the second step of the algorithm, the binary decisions are fixed, and an LP-model is now solved for all vaccination centres. Sequentially, the MILP-subproblems for each hub are solved and finally the optimal plan for the entirety of the supply chain is created. Often citizens do not come to the planned appointment or reschedule their appointment at the last minute. This is a known issue in COVID-19 VSCs that must be considered, In this section the developed optimization-based framework is tested. First, an illustrative example is used to test in detail the efficiency of the proposed MILP-model. Then, a large-scale problem that simulates the Greek COVID-19 VSC is studied and near-optimal planning decisions are generated by employing the proposed MILP-based solution strategy. Finally, the applicability of the replanning algorithm is illustrated even for extreme disturbances in the vaccination plan. All models and solution algorithms were developed using the GAMS 30.1 interface and all instances were solved in an Intel Core i7 @3.4Gz with 16GB RAM using the commercial solver CPLEX [34] . Let us assume a COVID-19 supply chain consisting of one hub and five vaccination centres. Two wages, and rental of the trucks, cover 3.8%, 9.3% and 6.1% of the total cost accordingly. Only 26 doses are lost translating to 1.8% of the total costs. No additional healthcare personnel are required; therefore, the associated cost term is zero. Table 1 To evaluate the developed MILP-based framework for realistically sized COVID-19 VSCs, the problem of the panhellenic vaccination program is simulated. The Greek state is using five hubs in total, whose exact locations are unknown due to security reasons. However, it is known that two are in the region of Attica, one in Thessaloniki, one in Karditsa and one in Crete. Based on this knowledge the locations of the hubs are approximately chosen. The hospitals and health centres of Greece as provided by the Hellenic Ministry of Health are used as vaccination centres. Except for Crete, which has its own hub, Greek islands are not considered in the study. As a result, a total of 351 vaccination centres are considered. Four vaccine types are available (P, M, A, J) each one produced and supplied exclusively by a single manufacturing plant. To create the required data, the population data of Greece from the Population and Housing Census conducted by the Hellenic Statistical Authority are used [35] . The population is divided based on the regional unity and the vaccination centres are allocated to their respective regional unit. To generate the vaccination targets for the considered horizon of 14 days, it is assumed that the vaccination program for the entirety of the population must be realized within 6 months. So, the total demand for each vaccination centre is divided by 12 to get the bi-weekly vaccination targets. To ensure the feasibility of the problem, the initial inventory in the hubs and the vaccination centres is enough to satisfy at least the vaccination demand of the first two time periods. Vaccine inventories in the manufacturing plants are not considered as they are irrelevant for the problem under consideration. The problem above is solved by employing the proposed MILP-based solution strategy. Each vaccination centre is allocated to a single hub based on the geographical criteria. For the aggregation step of the solution algorithm, the 351 vaccination centres are grouped into 54 clusters based on their regional unit. Detailed data of the considered problem instance e.g. maximum vaccine supply, distance matrix, hub to vaccination centres connectivity and vaccination centres to clusters allocation, are provided in Tables S12 -S17 of the supplementary material. To generate nearoptimal solutions for the entirety of the supply chain, five individual subproblems, one for each hub are solved. First the clusters are considered, and aggregate solutions are proposed and then the detailed solutions for all vaccination centres of the subproblems are generated. The solver terminates either when the computational time limit of one hour (3600 seconds) is exceeded, or when an optimality gap of 5% is achieved. Table 2 portrays the solution statistics for all iterations of the individual subproblems. It is shown that the computational time limit is reached for the more complicated cases (H1, H2 and H3) in the first step of the solution strategy. However, the optimality gaps achieved are very close to the desired target of 5%. This target has been chosen, since a solution with a proven optimality gap of 5% can be considered as optimal. It must be noticed that for these cases relatively good optimality gaps (15%-20%) were achieved in very low CPU times, of around 15 minutes, displaying the model's capability of quickly proposing good solutions for complex problems. On the contrary, subproblems H4 and H5 are promptly solved to optimality. The time required for the second step is very low in comparison. Even the most difficult subproblem (H1) is resolved within three minutes. Comparing the problem sizes of the first and second step it is observed that the aggregated approach significantly reduces the number of variables and equations, which makes feasible the consideration of large and complex problem instances. The computational time required in total is close to 3.5 hours, however the utilization of parallel computing techniques reduces it to around 1 hour. Optimal solutions are generated for the smaller subproblems, while larger, more difficult subproblems may not be solved to optimality, but the reported integrality gaps (<8%), signify a solution close to the optimal one (5%). Table S18 of the supplementary material. Figure 6 illustrates the inventory profiles in each of the hubs and aggregated for all vaccination centres. It is noticed that the stored amounts are sustained relatively low to reduce as much as possible the storage costs. This is especially evident for the Pfizer-type and Moderna-type vaccines, which consistently do not remain in storage, rather they are used as fast as possible. This is expected since the mRNA vaccines are stored using special technologies that impose high operational costs. The stored amounts are increased in the end of the horizon to satisfy safety stock requirements. Low quantities of Pfizer-type vaccine are observed in the inventory profiles of the vaccination centres which ensure that the vaccines are not spoiled due to perishability issues. Moreover, the inventories of the vaccination centres at the end of Saturdays (time periods 6 and 13) are practically zero since it is assumed that no vaccinations are done on Sundays. In the presented example the vaccination centres have been grouped based on political boundaries. However, different clustering methods could be applied in other VSC problems. To address the impact the number of clusters employed have in the quality of the solutions generated, the following sensitivity analysis is included. Employing the proposed solution strategy, a large-sized problem of 106 vaccination centres is considered. A total of six instances are solved, considering alternative grouping of the vaccination centres into clusters. More specifically, 10 to 15 clusters are used in the studied instances. Table 3 summarizes the results of this analysis. As expected, using less clusters results to smaller MILP models in the first step. Therefore, the aggregated solution extracted is closer to the theoretically optimal, since smaller integrality gaps are achieved. However, aggregating the vaccination centres into fewer clusters, leads to worse solutions, when dealing with the real VSC problem. In particular, the generated LP model in the second step leads to worse detailed solutions for the vaccination centres. Interestingly, using 10 or 11 clusters in the studied example results to infeasibly solutions. Therefore, extremely aggregating the vaccination centres into very few clusters at hand should be strongly avoided. Conclusively the selected number of clusters should be as maximum as possible in order to respect the computational solution limitations. In this subsection the problem of replanning the COVID-19 VSC in case of disturbances due to citizens not arriving to scheduled appointments is studied. The case study used replicates the subproblem of hub H1 from the Greek nationwide problem presented in the previous section. First, the model is solved for the initial 14-day horizon. At the end of the first period, the decision makers gather the following information. All scheduled appointments were completed in only 26 vaccination centres. In 15 of them 5% of the appointments were not realized, while 10% and 15% of the citizens did not arrive in the appointments in 44 and 21 vaccination centres accordingly. Similarly, in the second period, the percentage of unrealized appointments was 2% in 45, 8% in 11 and 12% in 30 vaccination centres, while on the third period these were 4% in 30, 10% in 40 and 25% in 6 vaccination centres. Those disturbances call for the immediate replanning of the supply chain since the actual inventory profiles are significantly different to the planned ones. Therefore, when the new information becomes available, the proposed solution strategy is employed to reactively replan the supply chain. The cost distribution after every iteration of the solution algorithm is shown in Table 4 . It is observed that despite the significant disturbances, the costs remain low. Interestingly, very few Table S19 of the supplementary material. In this work, the optimal planning of the COVID-19 VSC is considered. Specific problem characteristics, such as special cold storage requirements, extremely limited shelf-life of some The authors declare that they have not known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The importance of vaccine supply chains to everyone in the vaccine world Strategic supply chain optimization for the pharmaceutical industries Capacity planning under uncertainty for the pharmaceutical industry Pharmaceutical supply chains: key issues and strategies for optimisation Planning and scheduling of industrial supply chains with reverse flows : A real pharmaceutical case study A supply chain generalized network oligopoly model for pharmaceuticals under brand differentiation and perishability Coordinating a green reverse supply chain in pharmaceutical sector by negotiation Emerging Challenges and Opportunities in Pharmaceutical Manufacturing and Distribution Hybridization of tabu search with feasible and infeasible local searches for periodic home health care logistics Rich vehicle routing with auxiliary depots and anticipated deliveries: An application to pharmaceutical distribution Toward an integrated sustainable-resilient supply chain: A pharmaceutical case study A possibilistic location-inventory model for multi-period perishable pharmaceutical supply chain network design Fast genetic algorithm approaches to solving discrete-time mixed integer linear programming problems of capacity planning and scheduling of biopharmaceutical manufacture Precision healthcare supply chain design through multi-objective stochastic programming Autologous CAR T-cell therapies supply chain: challenges and opportunities? Optimization of CAR Tcell therapies supply chains The impact of making vaccines thermostable in Niger ' s vaccine supply chain The imperative for stronger vaccine supply and logistics systems Integration of vaccine supply chains with other health commodity supply chains: A framework for decision making Removing the regional level from the Niger vaccine supply chain The benefits of redesigning Benin ' s vaccine supply chain Re-designing the Mozambique vaccine supply chain to improve access to vaccines A review of integrated supply chain network design models: Key issues for vaccine supply chains Literature review: The vaccine supply chain Mathematical programming models for supply chain production and transport planning Multiobjective optimisation of production, distribution and capacity planning of global supply chains in the process industry Planning a sustainable reverse logistics system: Balancing costs with environmental and social concerns A planning model for the WHO-EPI vaccine distribution network in developing countries A planning model for the WHO-EPI vaccine distribution network in developing countries Design and Planning of Sustainable Vaccine Supply Chain Optimal Design and Operation of WHO-EPI Vaccine Distribution Chains Resources , Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic Revising global indicative wastage rates: a WHO initiative for better planning and forecasting of vaccine supply needs GAMS-A User's Guide Population-Housing Census ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: 1 27202 47520 7548 18580 846 954 21330 123981 2 22703 44329 6280 15457 1337 1080 21330 112517 3 24401 37839 5442 13395 803 1018 21330 104228 4 24202 37367 5676 13971 791 1022 21330